Resources

For US sponsors, CROs and institutions: the IND and expanded-access contexts in which Canadian-registered medicines are lawfully imported, what the importer needs, and why Canada is a practical comparator source.

Why a molecule-level supply graph beats a supplier directory when a presentation goes short, what it contains, how to use it in minutes, and where its limits are.

The four shortage registers Nexara Health tracks use different definitions. How to read Canadian, US, Dutch and French records together to decide whether a shortage is local or systemic.

For Nordic and German distributors: how named-patient exemption routes work, what Canadian registration data tells you about source availability, and how partners work with Nexara Health.

A practical guide for Canadian clinicians and hospital pharmacists to the Special Access Programme: when it applies, how to file, what the supplier needs, and what happens after supply.

For UK importers and specials pharmacies: the regulation 167 exemption, WDA(H) and MHRA import notification, why Canadian DIN products are a practical source, and the document pack Nexara Health supplies.

A step-by-step checklist for hospital and clinic procurement when a medicine is short, dormant or not marketed in Canada — which route applies, what to verify, and what to ask a supplier for.

How comparator supply actually runs for a Canadian trial: specification, Division 5 basis, sourcing documentation, blinding sites, depot release and realistic timelines.

The licences, exceptions and documents behind lawful pharmaceutical import and export in Canada: DEL activities, SAP, exceptional importation, Division 5, GDP transport and controlled substances.

Comparator supply is where a trial buys the commercial drug it is testing against. This guide sets out what a sponsor or CRO should require from a comparator supplier: provenance, documentation, cold chain, and the ability to source across markets.

When a medicine a patient needs is not marketed in Canada, or is in shortage, there are lawful routes to bring it in. This guide explains the Special Access Programme, exceptional importation during shortages, and what a licensed wholesaler does at each step.

Every drug authorized for sale in Canada has an eight-digit Drug Identification Number. This guide explains what each field in a DIN record means, what the Health Canada status values actually tell you, and how to use Nexara's DIN and molecule pages.

Each week Nexara compares the full Health Canada Drug Product Database against the previous week's snapshot and publishes every status and company change. Here is what the digest contains and how buyers use it.

Plain-language definitions of the terms that come up in Canadian pharmaceutical sourcing — DIN, DEL, SAP, foreign pack, named patient, comparator, IOR/EOR, cold chain and more.